002422 Stock Overview Researches, develops, manufactures, distributes, and sells pharmaceutical products in China. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteSichuan Kelun Pharmaceutical Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Sichuan Kelun Pharmaceutical Historical stock prices Current Share Price CN¥29.48 52 Week High CN¥35.49 52 Week Low CN¥21.60 Beta 0.065 1 Month Change -14.53% 3 Month Change -7.88% 1 Year Change 3.33% 3 Year Change 52.19% 5 Year Change 22.83% Change since IPO 70.60%
Recent News & Updates
Sichuan Kelun Pharmaceutical Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥0.42 (vs CN¥0.38 in 3Q 2023) Oct 29
Sichuan Kelun Pharmaceutical Co., Ltd. Announces 2024 Interim Profit Distribution Plan to Be Implemented (A Shares), Payable on 23 October 2024 Oct 18
Investor sentiment improves as stock rises 22% Sep 30
Sichuan Kelun Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Sichuan Kelun Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for the First Half of 2024 Aug 30 See more updates
Sichuan Kelun Pharmaceutical Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 Dec 31
Third quarter 2024 earnings released: EPS: CN¥0.42 (vs CN¥0.38 in 3Q 2023) Oct 29
Sichuan Kelun Pharmaceutical Co., Ltd. Announces 2024 Interim Profit Distribution Plan to Be Implemented (A Shares), Payable on 23 October 2024 Oct 18
Investor sentiment improves as stock rises 22% Sep 30
Sichuan Kelun Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Sichuan Kelun Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for the First Half of 2024 Aug 30
Sichuan Kelun Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Jun 29
Sichuan Kelun Pharmaceutical Co., Ltd. Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 29 May 2024 May 25
Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 Apr 27
First quarter 2024 earnings released: EPS: CN¥0.67 (vs CN¥0.57 in 1Q 2023) Apr 26
Full year 2023 earnings released: EPS: CN¥1.69 (vs CN¥1.22 in FY 2022) Apr 11
Sichuan Kelun Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024 Mar 30
Investor sentiment improves as stock rises 15% Feb 07
Sichuan Kelun Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024 Dec 30
Third quarter 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.38 in 3Q 2022) Nov 01
Second quarter 2023 earnings released: EPS: CN¥0.41 (vs CN¥0.43 in 2Q 2022) Aug 30
Sichuan Kelun Pharmaceutical Co., Ltd. Announces Cash Dividend on Share A for 2022, Payable on May 15, 2023 May 10
Sichuan Kelun Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022 May 06
Full year 2022 earnings released: EPS: CN¥1.22 (vs CN¥0.78 in FY 2021) Apr 14
Investor sentiment improved over the past week Dec 28
High number of new directors Nov 16
Third quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.25 in 3Q 2021) Oct 31
Investor sentiment improved over the past week Oct 19
High number of new directors Oct 08
Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.23 in 2Q 2021) Aug 31 Sichuan Kelun Pharmaceutical Co., Ltd. Announces Final Distribution for the Year 2021, Payable on 16 May 2022 May 10
Investor sentiment improved over the past week May 03
First quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.12 in 1Q 2021) Apr 28
Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) announces an Equity Buyback for CNY 200 million worth of its shares. Apr 27
High number of new directors Apr 27
Sichuan Kelun Pharmaceutical Co., Ltd., Annual General Meeting, May 05, 2022 Apr 13
Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021 Apr 12
Full year 2021 earnings released: EPS: CN¥0.78 (vs CN¥0.58 in FY 2020) Apr 11
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Jan 09
Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.21 in 3Q 2020) Oct 31
Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.10 in 2Q 2020) Aug 27
Sichuan Kelun Pharmaceutical Co., Ltd. announced that it expects to receive CNY 3 billion in funding Jun 18
Sichuan Kelun Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year 2020 Apr 29
Full year 2020 earnings released: EPS CN¥0.58 (vs CN¥0.66 in FY 2019) Apr 17
Investor sentiment improved over the past week Mar 18
New 90-day high: CN¥21.88 Feb 25
New 90-day low: CN¥18.06 Jan 07
New 90-day low: CN¥20.47 Dec 10
New 90-day low: CN¥21.62 Nov 24
Revenue misses expectations Nov 03
Third quarter earnings released Nov 01
Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) entered into an agreement to acquire Shanghai Century Acquisition Corporation (Amex: SHA) in a reverse merger transaction. Sep 23
First half earnings released Sep 05
New 90-day high - CN¥25.76 Sep 01
Sichuan Kelun Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020 Aug 14
New 90-day high - CN¥23.83 Aug 10 Shareholder Returns 002422 CN Pharmaceuticals CN Market 7D -3.3% -1.8% -1.7% 1Y 3.3% -8.0% 7.0%
See full shareholder returns
Return vs Market: 002422 underperformed the CN Market which returned 7% over the past year.
Price Volatility Is 002422's price volatile compared to industry and market? 002422 volatility 002422 Average Weekly Movement 5.9% Pharmaceuticals Industry Average Movement 6.7% Market Average Movement 8.2% 10% most volatile stocks in CN Market 12.2% 10% least volatile stocks in CN Market 5.1%
Stable Share Price: 002422 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002422's weekly volatility (6%) has been stable over the past year.
About the Company Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China.
Show more Sichuan Kelun Pharmaceutical Co., Ltd. Fundamentals Summary How do Sichuan Kelun Pharmaceutical's earnings and revenue compare to its market cap? 002422 fundamental statistics Market cap CN¥46.77b Earnings (TTM ) CN¥2.96b Revenue (TTM ) CN¥22.50b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 002422 income statement (TTM ) Revenue CN¥22.50b Cost of Revenue CN¥10.85b Gross Profit CN¥11.65b Other Expenses CN¥8.68b Earnings CN¥2.96b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 24, 2025
Earnings per share (EPS) 1.87 Gross Margin 51.76% Net Profit Margin 13.17% Debt/Equity Ratio 19.7%
How did 002422 perform over the long term?
See historical performance and comparison Dividends
1.8% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 01:11 End of Day Share Price 2025/01/02 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Sichuan Kelun Pharmaceutical Co., Ltd. is covered by 18 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Liang Long Chasing Securities Pei Cheng China Galaxy Securities Co., Ltd. Ziyu He China International Capital Corporation Limited
Show 15 more analysts